Cannabis Investment Report – Basic Endocannabinoid OverviewCannabis Investment Report – December 2017 Overview of Cannabinoids
Duplicate Document
This document appears to be a copy. The original version is:
Scientific overview of endocannabinoid system with no actionable leadsCase Filekaggle-ho-024655House OversightScientific overview of endocannabinoid system with no actionable leads
Unknown1p1 persons
Case File
kaggle-ho-024655House OversightScientific overview of endocannabinoid system with no actionable leads
Scientific overview of endocannabinoid system with no actionable leads The passage is a generic medical/scientific description of the endocannabinoid system, containing no names, transactions, dates, or allegations involving powerful actors. It offers no investigative leads. Key insights: Describes distribution of CB1/CB2 receptors in human peripheral organs.; Explains function of endocannabinoids like anandamide.; Notes presence of endocannabinoid system in animals and potential therapeutic uses.
Date
Unknown
Source
House Oversight
Reference
kaggle-ho-024655
Pages
1
Persons
1
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
Advertisement
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, donor-supported, and independent. Donors see no ads.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.